Numeric Investors’s Myriad Genetics MYGN Stock Holding History

Numeric Investors’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$903K	Buy	+26,300	New	+$887K	0.01%	764
2017 Q2	–	Sell	-106,500	Closed	-$2.04M	–	1106
2017 Q1	$2.04M	Buy	106,500 +11,600	+12%	+$206K	0.02%	476
2016 Q4	$1.58M	Sell	94,900 -10,600	-10%	-$192K	0.01%	548
2016 Q3	$2.17M	Sell	105,500 -303,700	-74%	-$7.7M	0.02%	458
2016 Q2	$12.5M	Buy	409,200 +349,600	+587%	+$12.1M	0.11%	187
2016 Q1	$2.23M	Sell	59,600 -34,900	-37%	-$1.32M	0.02%	418
2015 Q4	$4.08M	Buy	+94,500	New	+$3.99M	0.04%	326
2015 Q3	–	Sell	-7,600	Closed	-$258K	–	1094
2015 Q2	$258K	Buy	+7,600	New	+$258K	﹤0.01%	801
2014 Q2	–	Sell	-19,400	Closed	-$663K	–	861
2014 Q1	$663K	Sell	19,400 -155,700	-89%	-$4.82M	0.01%	522
2013 Q4	$3.67M	Buy	+175,100	New	+$4.43M	0.06%	266

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors's MYGN Position: Q4 2017 in Review

Numeric Investors opened a new position in Myriad Genetics (MYGN) in Q4 2017: 26,300 shares worth $903K. The stake represents 0.01% of the portfolio and ranks #764 among its holdings. This is a return to the name: Numeric Investors previously reported a position in MYGN as recently as Q1 2017.

Numeric Investors first reported a position in MYGN in Q4 2013 and has held it in 10 quarters since. The position peaked at $12.5M in Q2 2016. 250 funds tracked by Wall St. Rank hold MYGN as of Q4 2017.

Numeric Investors held 26,300 shares of Myriad Genetics worth $903K as of Q4 2017.
Myriad Genetics was a new Numeric Investors position in Q4 2017.
Myriad Genetics made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #764 holding.
Numeric Investors first reported a position in Myriad Genetics in Q4 2013 and has held it in 10 quarters since.
Numeric Investors's Myriad Genetics position peaked at $12.5M in Q2 2016.
250 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.